BusinessBioStem Technologies, Inc. Announces Letter of Intent with CCM Pharma Solutions to Co-Develop Multiple Solid to Liquid Dose Drugs Through 505(b)(2) Accelerated FDA Approval ProcessBy Nasdaq OMXMar 26, 2018, 11:22 PM UTC
BusinessDAS Health Partners with LinkedMD to Provide Chronic Care Management ServicesBy Nasdaq OMXSep 13, 2016, 12:00 PM UTC
